Elixxer Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.024x

Elixxer Ltd cash flow conversion efficiency. Based on the latest financial reports, Elixxer Ltd (ELXR) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-367.24K ≈ $-265.66K USD) by net assets (CA$-15.05 Million ≈ $-10.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Elixxer Ltd (2017–2024)

Cash flow conversion efficiency of Elixxer Ltd from 2017 to 2024. This chart illustrates how Elixxer Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Elixxer Ltd stock quote for real-time trading data and today's change.

Elixxer Ltd Cash Flow Conversion Ratio Explained

Elixxer Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Elixxer Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Elixxer Ltd ranked by their cash flow conversion efficiency. Also see Elixxer Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Multistack International Ltd AU:MSI	-0.834x
Renalytix AI plc LSE:RENX	4.746x
Tongaat JSE:TON	1.602x
Itaconix plc LSE:ITX	-0.059x
M Winkworth PLC LSE:WINK	0.190x
Altair Resources Inc V:AVX	0.002x
Annum Bhd KLSE:5082	0.001x
Lytus Technologies Holdings PTV. Ltd. Common Shares NASDAQ:LYT	0.005x

Annual Cash Flow Conversion Efficiency for Elixxer Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Elixxer Ltd from 2017 to 2024. Review ELXR cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-13.09 Million ≈ $-9.47 Million	CA$0.00 ≈ $0.00	0.000x	--
2023-12-31	CA$-9.60 Million ≈ $-6.94 Million	CA$-2.40 Million ≈ $-1.74 Million	0.250x	-53.81%
2022-12-31	CA$-5.58 Million ≈ $-4.04 Million	CA$-3.02 Million ≈ $-2.19 Million	0.541x	+212.79%
2021-12-31	CA$8.38 Million ≈ $6.06 Million	CA$-4.02 Million ≈ $-2.91 Million	-0.480x	+24.26%
2020-12-31	CA$4.76 Million ≈ $3.44 Million	CA$-3.01 Million ≈ $-2.18 Million	-0.633x	-148.31%
2018-12-31	CA$17.67 Million ≈ $12.79 Million	CA$-4.51 Million ≈ $-3.26 Million	-0.255x	+84.87%
2017-12-31	CA$1.58 Million ≈ $1.14 Million	CA$-2.66 Million ≈ $-1.92 Million	-1.685x	--

About Elixxer Ltd

V:ELXR Canada Drug Manufacturers - Specialty & Generic

Market Cap

$287.08K

CA$396.86K CAD

Market Cap Rank

#31268 Global

#1666 in Canada

Share Price

CA$0.04

Change (1 day)

+0.00%

52-Week Range

CA$0.03 - CA$1.15

All Time High

CA$99.00